Riskpilot← Back to searchSign inGet full accessDoktor Stefan Lewold AB
ABActiveOrg 5567658074Kyrkogatan 19General medical practice activities · NACE 8621Est. 20083 employees
Revenue 2025
SEK 4,2M
-13% vs 2024
EBITDA margin
16.6%
-41% vs 2024
Equity ratio
23.5%
Financial strength
Net profit 2025
SEK 605K
-16% vs 2024
| Revenue | SEK 4,2M | -13% |
| EBITDA | SEK 702K | -41% |
| Net profit | SEK 605K | -16% |
| Total assets | SEK 4,4M | -8% |
| Equity | SEK 1M | -16% |
| Employees | 3 | — |
Legal name
Doktor Stefan Lewold AB
Org number
5567658074
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
15 september 2008
Share capital
SEK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva läkarverksamhet samt konsultverksamhet inom it-området samt därmed förenlig verksamhet.
Address
Kyrkogatan 19
Phone
+46464601010
Email
stefan@clemenskliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 517 | 5 146 | 4 886 | 4 874 | 4 232 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 980 | 2 049 | 1 459 | 1 193 | 702 |
| Depreciation & amort. | −5 | −5 | −5 | −5 | −0 |
| EBIT | 1 975 | 2 044 | 1 454 | 1 188 | 702 |
| Net financials | −1 | — | 7 | 85 | 39 |
| Profit before tax | 1 519 | 1 518 | 1 002 | 927 | 786 |
| Tax | −329 | −320 | −221 | −211 | −181 |
| Net profit | 1 190 | 1 198 | 781 | 716 | 605 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 917 | 5 515 | 4 934 | 4 813 | 4 416 |
| Equity | 1 336 | 1 534 | 1 315 | 1 231 | 1 037 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 482 | 1 657 | 1 226 | 1 216 | 1 184 |
| Total debt | 2 482 | 1 657 | 1 226 | 1 216 | 1 184 |
EBITDA margin
16.6%
This company
15.8%
Market median
+5% vs market
20212025
Equity ratio
23.5%
This company
38.2%
Market median
-38% vs market
20212025
Return on equity
58.3%
This company
18.4%
Market median
+217% vs market
20212025
Net profit margin
14.3%
This company
8.1%
Market median
+77% vs market
20212025
Asset turnover
0.96×
This company
1.12×
Market median
+14% vs market
20212025
Debt / equity
3.26×
This company
0.62×
Market median
-426% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RV Chief Auditor | Chief Auditor | 2025 |
| Former (1) | ||
LG Chief Auditor | Chief Auditor | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Doktor Stefan Lewold AB 
ManuFix Scandinavia ABBoard members of Doktor Stefan Lewold AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Göran Axel Johansson Gren | Chief Auditor | 0 companies |
| Robin Victor Mattias Pilebäck | Chief Auditor | 0 companies |
| Stefan Hjalmar Ottosson Lewold | Board of Directors | 0 companies |
| Christer Hjalmar Ottosson Lewold | Deputy Board Member | 0 companies |